Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Opris, DanielaErdes, ShandorGrazio, SimeonSenolt, LadislavHojnik, MajaNagy, OrsolyaMarina, DianaSzántó, Sándor2019-03-042019-03-042018Drugs in Context. -7 (2018), p. 1-8. -Drugs Context. - 1745-1981. - 1740-43981740-43981745-1981http://hdl.handle.net/2437/264178Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countriesfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM077484OrvostudományokKlinikai orvostudományokhttps://www.drugsincontext.com/impact-of-adalimumab-on-clinical-outcomes-healthcare-resource-utilization-and-sick-leave-in-patients-with-ankylosing-spondylitis-an-observational-study-from-five-central-and-eastern-european-countrieshttp://dx.doi.org/10.7573/dic.2125562019-03-13